Steven Tau

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Replacement Therapy

Decision Making

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy Without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy Without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Steven Tau, Todd W Miller
Alpelisib Efficacy without Cherry-PI3King Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Nicole A Traphagen, Gary N Schwartz, Steven Tau, Alyssa M Roberts, Amanda Jiang, Sarah R Hosford, Jonathan D Marotti, Abigail E Goen, Bianca A Romo, Anneka L Johnson, Emily-Claire K Duffy, Eugene Demidenko, Paul Heverly, Yaron Mosesson, Shannon M Soucy, Fred Kolling Iv, Todd W Miller
Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)